Exploring the Effectiveness and Factors Affecting the Collection of Single Nucleated Cells From Different Volunteers
NCT06361602 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2024-04-12
Summary
1. 80 cases of healthy donors were subjected to peripheral blood single nucleated cells (PBMC) collection and analyzed the effects of age, body mass index (BMI), blood routine indexes before collection, collection of circulating blood volume, volume of processed blood and the number of circulations, etc., on the PBMC obtained from both men and women, and explored the effects of PBMC collection in different volunteers and the factors affecting the collection. and the influencing factors.
2. The data obtained will provide a reference for the MNC threshold for the subsequent clinical trials of immunocell therapy in hospitals.
3. From the screening of volunteers, PBMC collection and transportation conditions and other specific details of the operation, risk assessment and the establishment of a safe operation standard process, for the hospital to carry out subsequent clinical trials of immune cell therapy to provide an effective reference.
Conditions
- Observational Study
Interventions
- OTHER
-
inapplicable
inapplicable
Sponsors & Collaborators
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-01
- Primary Completion
- 2027-05-01
- Completion
- 2027-05-01
More Related Trials
-
Engineered Immune Effectors Against Cervical Cancer
NCT03362619 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety Study of Adoptive Transfer of Autologous IKDC-like Cells
NCT02661685 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes
NCT05371730 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy
NCT03325036 ·Status: COMPLETED
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
Collection of Data and Samples From Healthy Donors for Use in Translational Research
NCT00090662 ·Status: RECRUITING
-
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
NCT03207854 ·Status: RECRUITING
-
Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients
NCT02766348 ·Status: UNKNOWN ·Phase: PHASE2
-
Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells
NCT03535246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma
NCT00862303 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors
NCT03114566 ·Status: TERMINATED
-
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
NCT05235607 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma
NCT04162158 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Prospective Study of White Blood Cells
NCT04838171 ·Status: RECRUITING
-
NK Cell Therapy Recurrent/Refractory Elderly AML
NCT04599452 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Neoantigen Derived DCs as Cancer Treatment
NCT05767684 ·Status: RECRUITING ·Phase: PHASE1
-
Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors
NCT04765462 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer
NCT03113019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Single Arm Clinical Study of Dendritic Cell Vaccine Loaded With Circular RNA Encoding Cryptic Peptide for Patients With HER2-negative Advanced Breast Cancer
NCT06530082 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
NK Cell Infusion for Patients With Acute Myeloid Leukemia
NCT04221971 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection
NCT01914263 ·Status: UNKNOWN ·Phase: PHASE1
-
DC/NK Cell Therapy
NCT07202611 ·Status: RECRUITING ·Phase: PHASE2
-
Lymphocytes Subpopulation in Cancer Patients
NCT02516371 ·Status: UNKNOWN ·Phase: NA
-
NK Cells Infusion for Advanced Malignancies
NCT03619954 ·Status: UNKNOWN ·Phase: PHASE1
-
DC Vaccine Combined With CIK Cells in Patients With SCLC
NCT02688673 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2